BriaCell Therapeutics Receives $12.9 Million From Warrant Exercises
BriaCell Therapeutics Corp. (TSXV: BCT) announced today that they have received gross proceeds from exercised warrants amounting to US$12.9 million.
Read moreBriaCell Therapeutics Corp. (TSXV: BCT) announced today that they have received gross proceeds from exercised warrants amounting to US$12.9 million.
Read more